Abbott Laboratories
ABT
A$189.91
Share price
2.62%
Change (1 day)
26.90%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Abbott Laboratories (ABT) - Total assets
Total assets on the balance sheet as of March 2025 : A$125.07 Billion
According to Abbott Laboratories's latest financial reports the company's total assets are A$125.07 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Abbott Laboratories - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | A$130.89 B | 21.8% |
| 2023-12-31 | A$107.46 B | -1.76% |
| 2022-12-31 | A$109.38 B | 5.46% |
| 2021-12-31 | A$103.72 B | 9.93% |
| 2020-12-31 | A$94.34 B | -2.69% |
| 2019-12-31 | A$96.96 B | 1.69% |
| 2018-12-31 | A$95.35 B | -2.37% |
| 2017-12-31 | A$97.66 B | 33.68% |
| 2016-12-31 | A$73.06 B | 29.04% |
| 2015-12-31 | A$56.61 B | 12.45% |
| 2014-12-31 | A$50.35 B | 4.56% |
| 2013-12-31 | A$48.15 B | -25.57% |
| 2012-12-31 | A$64.69 B | 10.06% |
| 2011-12-31 | A$58.78 B | -1.42% |
| 2010-12-31 | A$59.63 B | 2.2% |
| 2009-12-31 | A$58.35 B | -2.95% |
| 2008-12-31 | A$60.12 B | 32.36% |
| 2007-12-31 | A$45.42 B | -1.02% |
| 2006-12-31 | A$45.89 B | 15.23% |
| 2005-12-31 | A$39.82 B | 7.13% |
| 2004-12-31 | A$37.17 B | 6.12% |
| 2003-12-31 | A$35.03 B | -18.64% |
| 2002-12-31 | A$43.05 B | -5.67% |
| 2001-12-31 | A$45.64 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | A$297.40 B | 137.78% | 🇺🇸 USA |
 Pfizer PFE | A$319.44 B | 155.41% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | A$152.08 B | 21.60% | 🇺🇸 USA |
 Hologic HOLX | A$13.12 B | -89.51% | 🇺🇸 USA |
 Medtronic MDT | A$140.78 B | 12.56% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | A$141.93 B | 13.48% | 🇺🇸 USA |
 Boston Scientific BSX | A$61.63 B | -50.72% | 🇺🇸 USA |
 AstraZeneca AZN | A$163.16 B | 30.46% | 🇬🇧 UK |
 Novartis NVS | A$153.46 B | 22.71% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | A$120.44 B | -3.70% | 🇬🇧 UK |